Class 4 Drug Alert (caution in use): Diflucan powder for oral suspension (10mg/ml and 40mg/ml) -Pfizer Limited - EL (12)A/31
Pfizer Limited has recently amended the labels and Patient Information Leaflet (PIL) for the above products. They have informed the MHRA that there may be some confusion resulting from the new packaging. To ensure continuity of supply, distribution of affected stock will continue and it will be necessary to release further batches.
Steps are being taken to remedy this situation as quickly as possible, but it maybe several months before the issue is resolved.
Pfizer Limited has recently amended the labels and Patient Information Leaflet (PIL) for the above products. They have informed the MHRA that there may be some confusion resulting from the new packaging. To ensure continuity of supply, distribution of affected stock will continue and it will be necessary to release further batches.
Steps are being taken to remedy this situation as quickly as possible, but it maybe several months before the issue is resolved.
